SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Broadus AE 2003 Mineral balance and homeostasis. FavusMJ (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Caus Press, Washington, DC, USA, 105110.
  • 2
    Hoenderop JG, van der Kemp AW, Hartog A, de van Graaf SF, van Os CH, Willems PH, Bindels RJ 1999 Molecular identification of the apical Ca2+ channel in 1, 25-dihydroxyvitamin D3-responsive epithelia. J Biol Chem 274: 83758388.
  • 3
    Peng JB, Chen XZ, Berger UV, Vassilev PM, Tsukaguchi H, Brown EM, Hediger MA 1999 Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. J Biol Chem 274: 2273922746.
  • 4
    Feher JJ, Fulmer CS, Wasserman RH 1992 Role of facilitated diffusion of calcium by calbindin in intestinal calcium absorption. Am J Physiol Cell Physiol 262: C517C526.
  • 5
    Blaustein MP, Juhaszova M, Golovina VA, Church PJ, Staney EF 2002 Na/Ca exchanger and PMCA localization in neurons and astrocytes: Functional implications. Ann NY Acad Sci 976: 356366.
  • 6
    Hoenderop JG, Nilius B, Bindels RJ 2002 ECaC: The gatekeeper of transepithelial Ca2+ transport. Biochim Biophys Acta 1600: 611.
  • 7
    Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165176.
  • 8
    van Abel M, Hoenderop JG, van der Kemp AW, van Leeuwen JP, Bindels RJ 2003 Regulation of the epithelial Ca2+ channels in small intestine as studied by quantitative mRNA detection. Am J Physiol Gastrointest Liver Physiol 285: G78G85.
  • 9
    Cromphaut SJ, Dewerchin M, Hoenderop JG, Stockmans I, Van Herck E, Kato S, Bindels RJ, Collen D, Carmeliet P, Bouillon R, Carmeliet G 2001 Duodenal calcium absorption in vitamin D receptor-knockout mice: Functional and molecular aspects. Proc Natl Acad Sci USA 98: 1332413329.
  • 10
    Takeda S, Yoshizawa T, Nagai Y, Yamato H, Fukumoto S, Sekine K, Kato S, Matsumoto T, Fujita T 1999 Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: Studies using VDR knockout mice. Endocrinology 140: 10051008.
  • 11
    Pike JW, Shevde NK 2005 The vitamin D receptor. FeldmanD, PikeJW, GlorieuxF (eds.) Vitamin D,, 2nd ed. Elsevier, San Diego, CA, USA, 167191.
  • 12
    Zella LA, Kim S, Shevde NK, Pike JW 2006 Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Mol Endocrinol 20: 12311247.
  • 13
    Zierold C, Darwish HM, DeLuca HF 1995 Two vitamin D response elements function in the rat 1,25-dihydroxyvitamin D 24-hydroxylase promoter. J Biol Chem 270: 16751678.
  • 14
    Murayama A, Kim MS, Yanagisawa J, Takeyama K, Kato S 2004 Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J 23: 15981608.
  • 15
    Meyer M, Watanuki M, Kim Sm Shevde N, Pike JW 2006 The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. Mol Endocrinol 20: 14471461.
  • 16
    Meyer MB, Zella LA, Nerenz RD, Pike JW 2007 Characterizing early events associated with the activation of target genes by 1,25-dihydroxyvitamin D3 in mouse kidney and intestine in vivo. J Biol Chem 282: 2234422352.
  • 17
    Boyle WJ, Simonet WS, Lacey DL 2003 Osteoclast differentiation and activation. Nature 423: 337342.
  • 18
    Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315323.
  • 19
    Kitazawa R, Kitazawa S, Maeda S 1999 Promoter structure of mouse RANKL/TRANCE/OPGL/ODF gene. Biochim Biophys Acta 1445: 134141.
  • 20
    Kim S, Yamazaki M, Zella LA, Shevde NK, Pike JW 2006 Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers. Mol Cell Biol 26: 64696486.
  • 21
    Kim S, Yamazaki M, Shevde N, Pike JW 2007 Transcriptional control of receptor activator of NF-κB ligand by the protein kinase A activator forskolin and the GP130 activating cytokine oncostatin M is exerted through multiple distal enhancers. Mol Endocrinol 21: 197214.
  • 22
    Fu Q, Manolagas SC, O'Brien CA 2006 Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer. Mol Cell Biol 26: 64536468.
  • 23
    Galli C, Zella LA, Fretz JA, Fu Q, Pike JW, Weinstein RS, Manolagas SC, O'Brien CA 2008 Targeted deletion of a distant transcriptional enhancer of the receptor activator of nuclear factor (Kappa) B ligand gene reduces bone remodeling and increases bone mass. Endocrinology 149: 146153.